Issue 12, 2012

Ursane-type pentacyclic triterpenoids as useful platforms to discover anticancer drugs

Abstract

Covering: up to December 2011

This review highlights the potential of natural and semisynthetic ursane-type triterpenoids as candidates for the design of multi-target bioactive compounds, with focus on their anticancer effects. A brief illustration of the biosynthesis, sources, and general biological effects of the main classes of naturally occurring pentacyclic triterpenoids (PTs) are provided.

Graphical abstract: Ursane-type pentacyclic triterpenoids as useful platforms to discover anticancer drugs

Article information

Article type
Review Article
Submitted
04 May 2012
First published
09 Oct 2012

Nat. Prod. Rep., 2012,29, 1463-1479

Ursane-type pentacyclic triterpenoids as useful platforms to discover anticancer drugs

J. A. R. Salvador, V. M. Moreira, B. M. F. Gonçalves, A. S. Leal and Y. Jing, Nat. Prod. Rep., 2012, 29, 1463 DOI: 10.1039/C2NP20060K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements